Taipei Exchange - Delayed Quote TWD
ShareHope Medicine Co., Ltd. (8403.TWO)
28.30
-0.25
(-0.88%)
At close: 1:12:19 PM GMT+8
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
4,325,831
4,325,831
3,873,384
4,137,132
3,850,027
Cost of Revenue
3,611,427
3,611,427
3,147,007
3,153,221
3,016,071
Gross Profit
714,404
714,404
726,377
983,911
833,956
Operating Expense
524,968
524,968
604,185
646,820
591,022
Operating Income
189,436
189,436
122,192
337,091
242,934
Net Non Operating Interest Income Expense
-47,809
-47,809
-45,344
-35,024
-18,861
Pretax Income
173,910
173,910
108,984
339,938
267,629
Tax Provision
51,512
51,512
53,719
95,828
74,201
Net Income Common Stockholders
200,097
200,097
124,557
293,946
232,663
Diluted NI Available to Com Stockholders
200,097
200,097
124,557
293,946
232,663
Basic EPS
1.53
--
0.95
2.24
1.78
Diluted EPS
1.52
--
0.95
2.23
1.76
Basic Average Shares
130,782.35
--
131,112.63
131,085.76
131,084.77
Diluted Average Shares
131,642.76
--
131,112.63
131,982.24
132,350.40
Total Expenses
4,136,395
4,136,395
3,751,192
3,800,041
3,607,093
Net Income from Continuing & Discontinued Operation
200,097
200,097
124,557
293,946
232,663
Normalized Income
207,801.51
207,801.51
127,031.40
292,491.84
221,448.14
Interest Income
10,533
10,533
8,321
3,134
1,273
Interest Expense
58,342
58,342
53,665
38,158
20,134
Net Interest Income
-47,809
-47,809
-45,344
-35,024
-18,861
EBIT
232,252
232,252
162,649
378,096
287,763
EBITDA
539,816
539,816
483,224
685,245
592,288
Reconciled Cost of Revenue
3,611,427
3,611,427
3,147,007
3,153,221
3,016,071
Reconciled Depreciation
307,564
307,564
320,575
307,149
304,525
Net Income from Continuing Operation Net Minority Interest
200,097
200,097
124,557
293,946
232,663
Total Unusual Items Excluding Goodwill
-10,947
-10,947
-3,093
2,025
15,517
Total Unusual Items
-10,947
-10,947
-3,093
2,025
15,517
Normalized EBITDA
550,763
550,763
486,317
683,220
576,771
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-3,242.49
-3,242.49
-618.60
570.84
4,302.14
12/31/2021 - 3/1/2011
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
3716.TW Cenra Inc.
36.80
-0.67%
4164.TW CHC Healthcare Group
41.95
-2.21%
4104.TW Excelsior Medical Co., Ltd.
86.20
-0.58%
6637.TWO Medical Imaging Corporation
75.10
+1.89%
AMPm.XC
AMFPF Amplifon S.p.A.
22.02
0.00%
NVLG.TA Novolog (Pharm-Up 1966) Ltd
152.60
-1.93%
ARJO-B.ST Arjo AB (publ)
31.50
+1.35%
GALE.SW Galenica AG
85.00
-2.35%
AMP.VI Amplifon S.p.A.
19.25
+2.86%